(Philadelphia, PA) - Raymond S. Roginski, MD, PhD, has been appointed Assistant Professor in the Department of Anesthesia at the University of Pennsylvania School of Medicine.

Dr. Roginski attended Yale University, where he earned his BS and MS degrees in Molecular Biophysics and Biochemistry. He went on to receive another MS, his MD and PhD from the Albert Einstein College of Medicine of Yeshiva University. He performed his internship and residency in Anesthesiology at Albert Einstein Affiliated Hospitals in the Bronx, New York. Dr. Roginski was an Associate Professor of Anesthesia at the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School, before joining Penn.

Dr. Roginski's research focuses on perioperative neuroprotection and neurodegenerative diseases, including autism. His Anesthesia interests include invasive neuroradiology, cardiology, ENT (ear, nose & throat), urologic surgery, day surgery and resident teaching. While at UMDNJ-Robert Wood Johnson Medical School, he discovered and mapped a pair of glutamate receptor-like genes named GRINL1A (chromosome 15) and GRINL1B (chromosome 4) in humans. He and his colleagues have also found these genes in rats and mice. At Penn, he continues to investigate the function of these genes and their role in neuroprotection and/or autism. To support his research, he has received funding from the Foundation for Anesthesia Education and Research, the American Cancer Society, the National Science Foundation, the Foundation for the University of Medicine and Dentistry of New Jersey, and the New Jersey Governor's Council on Autism.

He is a member of the American Society of Anesthesiologists, the Society of Neurosurgical Anesthesia and Critical Care, the International Anesthesia Research Society and the Society for Neuroscience. His research has been published in several journals including Cell, Molecular Cell Biology, Cytogenetics and Cell Genetics, Proceedings of the National Academy of Sciences, Federation of European Biochemical Societies (FEBS) Letters and Anesthesia Clinics of North America.

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.

Share This Page: